Marcie A. Goldstein

Davis Polk advised the underwriters on the SEC-registered initial public offering by Progyny, Inc. of 11,500,000 common shares, consisting of 6,700,000 shares sold by Progyny and 4,800,000…

Davis Polk advised the underwriters in connection with the $726 million public offering of 17,287,878 shares of Class A common stock of Tradeweb Markets Inc. Tradeweb is traded on the…

Davis Polk advised the underwriters in connection with an initial public offering of 8,047,227 American Depositary Shares of Innate Pharma S.A. and a concurrent private placement of 4,452…

Davis Polk advised the global coordinators and bookrunners in connection with the $653 million SEC-registered secondary offering of 16,750,000 shares of Class A common shares of PagSeguro…

Davis Polk advised the representatives of the several underwriters in connection with the $132.8 million initial public offering of 8,300,000 shares of common stock of HBT Financial, Inc…

Davis Polk advised the underwriters in connection with the $150 million initial public offering of 10,000,000 American Depositary Shares of BioNTech SE. In addition, the underwriters have…

Davis Polk advised the underwriters in connection with the $439 million SEC-registered offering of common stock of Grocery Outlet Holding Corp. by certain existing stockholders of Grocery…

Davis Polk advised the underwriters in connection with the $97.75 million initial public offering of 6,516,667 shares of common stock of Aprea Therapeutics, Inc., which includes 850,000…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,303,030 shares of its common stock. The common stock is listed on the…

Davis Polk advised the underwriters in connection with the $100.3 million initial public offering of 7,187,500 shares of common stock of Oportun Financial Corporation, of which 4,873,356…